一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Biomolecules >>article
Biomolecules

Biomolecules

IF: 4.8
Download PDF

Dual PARP and RAD51 Inhibitory Drug Conjugates Show Synergistic and Selective Effects on Breast Cancer Cells

Published:3 July 2021 DOI: 10.3390/biom11070981 PMID: 34356606
Matthews M Malka, Julia Eberle, Kathrin Niedermayer, Darius P Zlotos, Lisa Wiesmüller

Abstract

The genetic principle of synthetic lethality has most successfully been exploited in therapies engaging Poly-ADP-ribose-polymerase (PARP) inhibitors to treat patients with homologous recombination (HR)-defective tumors. In this work, we went a step further following the idea of a local molecular cooperation and designed hybrid compounds M1-M3. The drug conjugates M1-M3 combine Olaparib, the first PARP inhibitor approved for clinical use, with Cpd 1, an inhibitor of RAD51 that blocks its HR functions and yet permits RAD51 nucleoprotein filament formation on single-stranded DNA. While in M2 and M3, the parental drugs are linked by -CO-(CH2)n-CO-spacers (n = 2 and 4, respectively), they are directly merged omitting the piperazine ring of Olaparib in M1. Monitoring anti-survival effects of M1-M3 in six breast cancer cell lines of different molecular subtypes showed that in each cell line, at least one of the drug conjugates decreased viability by one to two orders of magnitude compared with parental drugs. While triple-negative breast cancer (TNBC) cells with frequent BRCA1 pathway dysfunction were sensitive to spacer-linked hybrid compounds M1 and M2 regardless of their HR capacities, non-TNBC cells were responsive to the merged drug conjugate M1 only, suggesting different spatial requirements for dual inhibition in these two groups of cell lines. These results demonstrate that, depending on chemical linkage, dual PARP1-RAD51 inhibitory drugs can either sensitize non-TNBC and re-sensitize TNBC cells, or discriminate between these groups of cells.

Substances (6)

Materials
Procduct Name CAS Molecular Formula Supplier Price
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
Olaparib 763113-22-0 C24H23FN4O3 687 suppliers $11.00-$2147.10
AZD2281 763113-22-0 C24H23FN4O3 - Inquiry
AZD2281 763113-22-0 C24H23FN4O3 - Inquiry

Similar articles

IF:4.4

Inhibitory effects of circR-127aa on gastric cancer progression and tumor growth

Cellular signalling Lei Qiao, Wen Pan,etc Published: 22 November 2024
IF:6.9

Therapeutic effects of guanidine hydrochloride on breast cancer through targeting KCNG1 gene.

Biomedicine & Pharmacotherapy Mehdi Roshanian Bakhsh, Leila Rouhi,etc Published: 1 August 2023
行唐县| 沅江市| 湖北省| 巫溪县| 临汾市| 江永县| 东乡族自治县| 特克斯县| 简阳市| 佛坪县| 平泉县| 汤原县| 灯塔市| 莱西市| 尉氏县| 江津市| 鄱阳县| 行唐县| 合阳县| 沈丘县| 新营市| 西昌市| 镇江市| 沾益县| 江永县| 新巴尔虎右旗| 余江县| 磴口县| 墨竹工卡县| 河间市| 邵武市| 雷波县| 饶阳县| 保康县| 山丹县| 鸡东县| 惠东县| 丹凤县| 日喀则市| 白山市| 安阳市|